Edition:
United States

Mette Fraende

Carlsberg still confident of Russia growth after third-quarter downturn

Nov 13 2013

COPENHAGEN Danish brewer Carlsberg A/S is confident of a return to growth in key market Russia after regulations to curb alcohol abuse dented third-quarter results, although western European markets may not pick up for a year or two.

Carlsberg still confident of Russia growth after third-quarter downturn

Nov 13 2013

COPENHAGEN Danish brewer Carlsberg A/S is confident of a return to growth in key market Russia after regulations to curb alcohol abuse dented third-quarter results, although western European markets may not pick up for a year or two.

Carlsberg Q3 profit hurt as Russia, Asia revenue weaken

Nov 13 2013

COPENHAGEN Danish brewer Carlsberg reported falling operating profit in the third quarter, with eastern European sales hurt by falling consumption in Russia and much-needed Asian revenue stalled due to currency movements.

Carlsberg grabs Heinz veteran to cash in on Asian thirst

Nov 12 2013

COPENHAGEN Danish brewer Carlsberg has appointed former Heinz executive Christopher Warmoth as head of its Asia business to aim for a bigger share of the high-growth market to offset weak beer sales in recession-hit western Europe.

Carlsberg grabs Heinz veteran to cash in on Asian thirst

Nov 12 2013

COPENHAGEN Danish brewer Carlsberg has appointed former Heinz executive Christopher Warmoth as head of its Asia business to aim for a bigger share of the high-growth market to offset weak beer sales in recession-hit western Europe.

Drug pricing challenges diabetes king Novo Nordisk

Nov 05 2013

COPENHAGEN Drug pricing is emerging as a key challenge for Novo Nordisk, the world's biggest insulin producer, whose previously unstoppable growth has started to flag, according to the Danish firm's chief executive.

Novo offers shy outlook as diabetes drug sales miss

Oct 31 2013

COPENHAGEN Danish drugmaker Novo Nordisk missed forecasts for third-quarter profit and sales and gave a smaller than hoped growth outlook for next year, capped by a weakening dollar and slower growth of some of its best-selling drugs.

Novo's diabetes drug sales, outlook lags forecasts

Oct 31 2013

COPENHAGEN Danish drugmaker Novo Nordisk missed forecasts for third quarter profit and sales and gave a smaller than expected growth outlook for next year, capped by a weakening dollar and slower growth of some of its best-selling drugs.

Don't blame Europe, stick with reform: Danish PM

Oct 11 2013

COPENHAGEN Denmark's center-left prime minister, accused by her left-wing parliamentary backers of veering too far to the right, said on Friday the country had got through the worst of its economic crisis and should persevere with unpopular reforms.

Don't blame Europe, stick with reform - Danish PM

Oct 11 2013

COPENHAGEN Denmark's centre-left prime minister, accused by her left-wing parliamentary backers of veering too far to the right, said on Friday the country had got through the worst of its economic crisis and should persevere with unpopular reforms.

World News